Tyra Biosciences, Inc.
TYRA
$10.09
$0.020.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.82% | -25.09% | -41.46% | -59.97% | -44.04% |
| Total Depreciation and Amortization | 36.36% | 45.38% | 41.54% | 28.87% | 25.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.85% | 37.78% | 17.06% | 43.36% | 40.67% |
| Change in Net Operating Assets | 310,600.00% | -111.46% | 364.06% | 303.61% | 99.99% |
| Cash from Operations | -17.46% | -39.16% | -31.14% | -44.23% | -21.70% |
| Capital Expenditure | 37.34% | 13.77% | -570.74% | -744.44% | -139.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.21% | 32.05% | -- | -- | -- |
| Cash from Investing | 33.24% | 31.95% | -132,771.81% | -177,311.11% | -34,939.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.89% | 13,078.72% | 16,526.23% | 18,040.07% | 26,087.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -48.52% | -- | -- | -- | -- |
| Cash from Financing | -98.01% | 13,051.40% | 16,491.69% | 18,002.34% | 26,065.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,313.15% | 117.58% | -134.99% | -211.34% | 124.93% |